FDAnews
www.fdanews.com/articles/122431-raptor-pain-relief-compound-proves-effective-in-trial

Raptor: Pain Relief Compound Proves Effective in Trial

November 23, 2009
Development stage biotechnology company Raptor Pharmaceuticals Corp. said that its orally administered pain relief compound NGX426 proved effective in a variety of neuropathic pain states, citing positive data from a clinical trial.
RTTNews